Search Results 291-300 of 18468 for Relapse

1. Post-polio syndrome - Symptoms & causes - Mayo Clinic

   This syndrome causes a number of potentially serious symptoms that appear decades after the polio virus.

2. Burkitt lymphoma - Symptoms and causes - Mayo Clinic

   This is called a relapse. The risk of relapse is higher in people with cancer of the central nervous system. For people who have relapsed, the prognosis is ...

3. Escalating Dose Study in Subjects with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia - Mayo Clinic

   Escalating Dose Study in Subjects with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia.

4. Study Of SIM0500 Alone In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   ... Relapsed or Refractory Multiple Myeloma(RRMM). The trial is consisted of two parts, Part 1 (dose escalation) and Part 2 (dose optimization). In both parts ...

5. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   ... (relapsed) or do not respond to treatment (refractory). Navitoclax and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes ...

6. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

   This phase II trial studies how well isatuximab works in treating patients with primary amyloidosis that has come back or does not respond to treatment.

7. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

   Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis · Overview · Participation ...

8. Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

   Clinical Trials · Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma · More about research at Mayo Clinic · Mayo ...

9. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer. Print ...

10. A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia - Mayo Clinic

    This research study is studying Daratumumab as a possible treatment for Waldenström Macroglobulinemia. Participation eligibility. Participant eligibility ...